Elicio Therapeutics Inc. (ELTX) — Capital Reinvestment Ratio
Elicio Therapeutics Inc. (ELTX) has a Capital Reinvestment Ratio of 0.09x as of June 2022, meaning it reinvests 0% of its operating cash flow ($6.14 Million) in capital expenditures ($559.00K). Check Elicio Therapeutics Inc. tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Elicio Therapeutics Inc. Capital Reinvestment Ratio (2012–2013)
This chart tracks Elicio Therapeutics Inc.'s Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Elicio Therapeutics Inc..
Annual Capital Reinvestment Ratio for Elicio Therapeutics Inc. (2012–2013)
Year-by-year Capital Reinvestment Ratio for Elicio Therapeutics Inc. from 2012 to 2013. See Elicio Therapeutics Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2013 | 0.01x | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $1.07 Million | $47.73K | — |